Ravi Kiran Kaja, PhD, explains how USP’s industry-wide initiative aims to build confidence in trace-level extractables and leachables results.
Ravi Kiran Kaja
Advertisement
Ravi Kiran Kaja, PhD, Senior Principal Scientist, USP
Articles by Ravi Kiran Kaja
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Germany’s Medical Biotechnology Sector is Flourishing
2
PharmTech AI Pulse Check: Why Pharma Should Weigh In on FDA's Generative AI Paper
3
Three Targeted Delivery Deals: What CMC Teams Should Watch
4
Expedited IND Pilot Targets Sequential Delays Slowing First-in-Human Trials
5